Abstract. This study was undertaken to assess the mechanism by which prostaglandins of the E series inhibit glucose-induced insulin secretion in man. Acute insulin response (mean change 3\p=n-\10 min) to iv glucose (0.33 g/kg) was decreased by 40% during the infusion of prostaglandin E2 (10 \g=m\g/min) and glucose disappearance rates were reduced (P <0.05). Insulin response to arginine (5 g iv) and tolbutamide (1 g iv) were not affected by the same rate of prostaglandin E2 infusion. The inhibitory effect of prostaglandin E2 on glucoseinduced insulin secretion was prevented by theophylline (100 mg as a loading dose followed by a 5 mg/min infusion), a drug that increases the intracellular cAMP concentrations by inhibiting phosphodiesterase activity. Our data suggest the involvement of the adenylate cyclase system in the inhibitory action of prostaglandin E2 on glucose-induced insulin secretion in man.
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The initial confusion about the effects of prostaglandins (PG) on insulin secretion, arising for the main part from the conflicting results of the in vitro studies performed in different animal spe¬ cies (Robertson 1979) , was followed by an unceas¬ ing increase in experimental in vivo data indicat¬ ing that PG of the E series (PGE) inhibit the insulin response to glucose in several species, including rats (D'Onofrio et al. 1977; Sacca et al. 1975 ), dogs (Robertson et al. 1974 ) and humans Robertson & Chen 1977 (Giugliano et al. 1979 ). More recently, Giugliano et al. (1983) showed that endogenous, pancreatically produced PGE may play a role in the appearance of the typical biphasic pattern of insulin release following a square wave glucose stimulation in normal man. Despite this evidence, many important questions still remain and await answers. The more pressing of these questions concerns the mechanism of action of PGE in islet cells. Recent in vitro studies (Robertson et al. 1987) Blood samples were taken in the basal state (-30, -15, 0) and at 3, 5, 8, 10, 15, 30, 45 and 60 min after the iv pulse had been given.
In the other set of experiments, the insulin response to iv glucose (0.33 g/kg) was evaluated during the infusion of theophylline (100 mg as a loading dose followed by an infusion of 5 mg/min) or theophylline plus PGE2 (10 µg/min). These two experiments were done in the same subjects, performed in random order and separated by an interval of 7 days. Blood samples were collected in prechilled tubes containing 1.2 mg EDTA/ml of blood, kept on ice until the end of the study and then immediately centrifuged after each experiment. The resultant plasma was stored deep-frozen until assayed. Plasma glucose concentra¬ tions were measured by the glucose-oxidase method adapted to a Beckman glucose analyzer (Beckman In¬ struments, Fullerton, CA). The method used for the determination of plasma immunoreactive insulin (IRf) has been previously described (Giugliano et al. 1983 ).
The acute insulin response (mean 3 -10 min change) was calculated as the mean of the 3-, 5-, 8-and 10-min post-injection values for a given subject from which was subtracted the insulin level immediately before thè pulse for that subject. Glucose Ejfect of theophylline and PGE2 on insulin response to glucose Fig. 4 shows the influence of theophylline (top) and theophylline plus PGE2 (bottom) on glucoseinduced insulin secretion in normal subjects.
Theophylline significantly increased the acute in¬ sulin response to glucose, being 430 ±71.7 pmol/1 before and 581 + 86 pmol/1 (luring theophylline (F < 0.05). The plasma glucose peaks following the two consecutive glucose pulses given in the absence or presence of theophylline were not significantly different (18.2 ± 2.4 mmol/1 vs 18.5 ± 3.1 mmol/1, = NS). KG increased from 2.09 ± 0.18%/min to 2.31 ± 3.1%/min during theophyl¬ line infusion (P < 0.05, Table 1 ).
The infusion of theophylline prevented the inhibitory effect of PGE2 upon glucose-induced insulin release. In fact, the acute insulin response was 423 ±71.7 pmol/1 after the first pulse and 502 ± 86 pmol/1 after the second one given during (Giugliano et al. , 1983 ) and other (Robertson & Chen 1977; Robertson 1979) laboratories that the inhibition of the beta-cell response to glucose by PGE may represent specific inhibition of glucose-induced insulin secretion rather than a non-specific reset¬ ting of the beta-cell secretory activity to a lower level.
It is generally agreed that glucose stimulates insulin secretion by decreasing membrane per¬ meability to K+ which in turn opens voltagedependent Ca2+ channels thus increasing cytoso¬ lic free Ca2+ (Henquin 1978) . Other mechanisms, among which are the increased beta-cell content of cAMP, may be important as well (Cerasi 1985 (Charles et al. 1982; Lebrunetal. 1982 ).
